A Phase 1, Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211
Latest Information Update: 21 Jan 2021
At a glance
- Drugs Axelopran (Primary) ; Itraconazole
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Theravance
- 01 Jun 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 12 Apr 2012 New trial record